{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:11Z","timestamp":1792083611389,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:00:00Z","timestamp":1372464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40272-013-0038-0","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T11:10:11Z","timestamp":1372417811000},"page":"343-349","source":"Crossref","is-referenced-by-count":17,"title":["Glucocorticoids in the Management of Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.1007","volume":"15","author":[{"given":"Gaia","family":"Vannucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Marrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,29]]},"reference":[{"issue":"2","key":"38_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/B978-1-4160-6581-4.10014-7","volume-title":"Textbook of pediatric rheumatology","author":"F Benedetti De","year":"2011","unstructured":"De Benedetti F, Schneider R. Systemic juvenile idiopathic arthritis. In: Cassidy J, Petty R, Laxer RM, editors. Textbook of pediatric rheumatology. 6th ed. Philadelphia: Saunders; 2011. p. 236\u201348.","edition":"6"},{"issue":"2","key":"38_CR3","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens EM, Beukelman T, Gallo L, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343\u20138.","journal-title":"J Rheumatol"},{"issue":"99","key":"38_CR4","first-page":"377","volume":"25","author":"EG Bywaters","year":"1956","unstructured":"Bywaters EG, Isdale IC. The rash of rheumatoid arthritis and Still\u2019s disease. Q J Med. 1956;25(99):377\u201387.","journal-title":"Q J Med"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0950-3579(98)80018-6","volume":"2","author":"R Schneider","year":"1998","unstructured":"Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis. Bailliere Clin Rheum. 1998;2:245\u201371.","journal-title":"Bailliere Clin Rheum"},{"key":"38_CR6","author":"R Gurion","year":"2012","unstructured":"Gurion R, Lehman TJ, Moorthy LN. Systemic arthritis in children: a review of clinical presentation and treatment. Int J Inflam. 2012;. doi: 10.1155\/2012\/271569 .","journal-title":"Int J Inflam"},{"key":"38_CR7","first-page":"w13582","volume":"142","author":"R Cimaz","year":"2012","unstructured":"Cimaz R, Von Scheven A, Hofer M. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease. Swiss Med Wkly. 2012;142:w13582.","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"38_CR8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncprheum0084","volume":"2","author":"P Woo","year":"2006","unstructured":"Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatol. 2006;2(1):28\u201334.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"38_CR9","first-page":"165","volume":"20","author":"JG Schaller","year":"1977","unstructured":"Schaller JG. Juvenile rheumatoid arthritis: series 1. Arthritis Rheum. 1977;20(2):165\u201370.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"38_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00442095","volume":"135","author":"E Stoeber","year":"1981","unstructured":"Stoeber E. Prognosis in juvenile chronic arthritis: follow-up of 433 chronic rheumatic children. Eur J Pediatr. 1981;135(3):225\u20138.","journal-title":"Eur J Pediatr"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-4857-7_5","volume":"455","author":"BM Ansell","year":"1999","unstructured":"Ansell BM. Prognosis in juvenile arthritis. Adv Exp Med Biol. 1999;455:27\u201333.","journal-title":"Adv Exp Med Biol"},{"key":"38_CR12","first-page":"798","volume-title":"Oxford textbook of rheumatology","author":"RM Laxer","year":"2004","unstructured":"Laxer RM, Schneider R. Systemic-onset juvenile chronic arthritis. In: Isenberg DA, et al., editors. Oxford textbook of rheumatology. Oxford: Oxford University Press; 2004. p. 798\u2013810."},{"issue":"5","key":"38_CR13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier P, Allantaz F, Cimaz R, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011;70(5):747\u201354.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"38_CR14","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2396\u2013406.","journal-title":"N Engl J Med"},{"key":"38_CR15","author":"DJ Lovell","year":"2009","unstructured":"Lovell DJ, Giannini E, Kimura Y, et al. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis (sJIA). Arthritis Rheum. 2009;. doi: 10.1002\/art.27125 .","journal-title":"Arthritis Rheum"},{"issue":"25","key":"38_CR16","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2385\u201395.","journal-title":"N Engl J Med"},{"issue":"7","key":"38_CR17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.arcped.2010.04.001","volume":"17","author":"B Bader-Meunier","year":"2010","unstructured":"Bader-Meunier B, Wouters C, Job-Deslandrec C, et al. Recommandations pour la prise en charge de la forme systemique l\u2019arthrite juvenile idiopathique (maladie de Still). Arch Pediatr. 2010;17(7):1090\u20134.","journal-title":"Arch Pediatr"},{"issue":"7","key":"38_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1542\/pir.16-7-266","volume":"16","author":"JD Spahn","year":"1995","unstructured":"Spahn JD, Kamada AK. Special considerations in the use of glucocorticoids in children. Pediatr Rev. 1995;16(7):266\u201372.","journal-title":"Pediatr Rev"},{"issue":"8","key":"38_CR19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1590\/S0004-27302007000800012","volume":"51","author":"LF Chan","year":"2007","unstructured":"Chan LF, Storr HL, Grossman AB, et al. Pediatric Cushing\u2019s syndrome: clinical features, diagnosis, and treatment. Arq Bras Endocrinol Metabol. 2007;51(8):1261\u201371.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"38_CR20","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Giustina A. Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol. 2013;. doi: 10.1038\/nrendo.2013.5 .","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"38_CR21","first-page":"255","volume":"9","author":"C Dieguez","year":"1996","unstructured":"Dieguez C, Mallo F, Se\u00f1aris R, et al. Role of glucocorticoids in the neuroregulation of growth hormone secretion. J Pediatr Endocrinol Metab. 1996;9(3):255\u201360.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"38_CR22","first-page":"1296","volume":"29","author":"D Simon","year":"2002","unstructured":"Simon D, Fernando C, Czernichow P, et al. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol. 2002;29(6):1296\u2013300.","journal-title":"J Rheumatol"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000321245","volume":"20","author":"MO Savage","year":"2011","unstructured":"Savage MO, Simon D, Czernichow PC. Growth hormone treatment in children on chronic glucorticoid therapy. Endocr Dev. 2011;20:194\u2013201.","journal-title":"Endocr Dev"},{"issue":"5","key":"38_CR24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.pcl.2011.07.007","volume":"58","author":"N Mauras","year":"2011","unstructured":"Mauras N. Strategies for maximizing growth in puberty in children with short stature. Pediatr Clin North Am. 2011;58(5):1167\u201379.","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"38_CR25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/BOR.0b013e328356b0c2","volume":"24","author":"JM Burnham","year":"2012","unstructured":"Burnham JM. Inflammatory diseases and bone health in children. Curr Opin Rheumatol. 2012;24(5):548\u201353.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"38_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02555248","volume":"41","author":"S Varonos","year":"1987","unstructured":"Varonos S, Ansell BM, Reeve J. Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int. 1987;41(2):75\u20138.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"38_CR27","first-page":"831","volume":"34","author":"H Valta","year":"2007","unstructured":"Valta H, Lahdenne P, Jalanko H, et al. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34(4):831\u20136.","journal-title":"J Rheumatol"},{"issue":"1","key":"38_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jocd.2007.12.004","volume":"11","author":"N Bishop","year":"2008","unstructured":"Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD pediatric official positions. J Clin Densitom. 2008;11(1):29\u201342.","journal-title":"J Clin Densitom"},{"issue":"6","key":"38_CR29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jpeds.2012.07.057","volume":"161","author":"NS Ma","year":"2012","unstructured":"Ma NS, Gordon CM. Pediatric osteoporosis: where are we now? J Pediatr. 2012;161(6):983\u201390.","journal-title":"J Pediatr"},{"issue":"2","key":"38_CR30","first-page":"491","volume":"27","author":"C Lomater","year":"2000","unstructured":"Lomater C, Gerloni V, Gattinara M, et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10\u00a0years. J Rheumatol. 2000;27(2):491\u20136.","journal-title":"J Rheumatol"},{"issue":"5","key":"38_CR31","first-page":"148","volume":"29","author":"A Ravelli","year":"2011","unstructured":"Ravelli A, Lattanzi B, Consolaro A, et al. Glucocorticoids in paediatric rheumatology. Clin Exp Rheumatol. 2011;29(5):148\u201352.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"38_CR32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/rheumatology\/37.11.1240","volume":"37","author":"AO Adebajo","year":"1998","unstructured":"Adebajo AO, Hall MA. The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. J Rheumatol. 1998;37(11):1240\u20132.","journal-title":"J Rheumatol"},{"issue":"1","key":"38_CR33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03009749609082663","volume":"25","author":"P Picco","year":"1996","unstructured":"Picco P, Gattorno M, Buoncompagni A, Pistoia V, Borrone C. 6-Methylprednisolone \u201cmini-pulses\u201d: a new modality of glucocorticoid treatment in systemic onset juvenile chronic arthritis. Scand J Rheum. 1996;25(1):24\u20137.","journal-title":"Scand J Rheum"},{"issue":"10","key":"38_CR34","first-page":"1995","volume":"25","author":"MS Klein-Gitelman","year":"1998","unstructured":"Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol. 1998;25(10):1995\u20132002.","journal-title":"J Rheumatol"},{"issue":"8","key":"38_CR35","first-page":"2018","volume":"27","author":"Y Kimura","year":"2000","unstructured":"Kimura Y, Fieldston E, Devries-Vandervlugt B, et al. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2000;27(8):2018\u201324.","journal-title":"J Rheumatol"},{"issue":"3","key":"38_CR36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1759720X12441274","volume":"4","author":"L Clarke","year":"2012","unstructured":"Clarke L, Kirwan J. Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis. Adv Musculoskelet Dis. 2012;4(3):159\u201366.","journal-title":"Adv Musculoskelet Dis"},{"issue":"3","key":"38_CR37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0091270012444315","volume":"53","author":"H Derendorf","year":"2013","unstructured":"Derendorf H, Ruebsamen K, Clarke L, et al. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis. J Clin Pharmacol. 2013;53(3):326\u201333.","journal-title":"J Clin Pharmacol"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-1-4160-6581-4.10006-8","volume-title":"Textbook of pediatric rheumatology","author":"NT Ilowite","year":"2011","unstructured":"Ilowite NT, Laxer RM. Pharmacology and drug therapy. In: Cassidy J, Petty R, Laxer RM, et al., editors. Textbook of pediatric rheumatology. 6th ed. Philadelphia: Saunders; 2011. p. 71\u2013126.","edition":"6"},{"issue":"4","key":"38_CR39","first-page":"413","volume":"8","author":"C Job-Delsandre","year":"1990","unstructured":"Job-Delsandre C, Menkes CJ. Complications of intraarticular injections of triamcinolone hexacetonide in chronic arthritis in children. Clin Exp Rheumatol. 1990;8(4):413\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"38_CR40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465\u201382.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"38_CR41","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202\u20139.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"38_CR42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","volume":"64","author":"ES Dewitt","year":"2012","unstructured":"Dewitt ES, Kimura Y, Beukelman T, et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res. 2012;64(7):1001\u201310.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"38_CR43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1546-0096-10-31","volume":"10","author":"NT Ilowite","year":"2012","unstructured":"Ilowite NT, Sandborg CI, Feldman BM, et al. Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. Pediatr Rheumatol Online J. 2012;10(1):31.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"38_CR44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85(5):421\u20136.","journal-title":"Arch Dis Child"},{"issue":"5","key":"38_CR45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.berh.2009.08.003","volume":"23","author":"SJ Vastert","year":"2009","unstructured":"Vastert SJ, Kuis W, Grom AA. Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Best Pract Res Clin Rheumatol. 2009;23(5):655\u201364.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"38_CR46","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Pink I, Eulenburg C, et al. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J Pediatr. 2013;. doi: 10.1016\/j.jpeds.2012.11.081 .","journal-title":"J Pediatr"},{"issue":"1","key":"38_CR47","first-page":"108","volume":"19","author":"A Ravelli","year":"2001","unstructured":"Ravelli A, Viola S, De Benedetti F, et al. Dramatic efficacy of cyclosporine A in macrophage activation syndrome. Clin Exp Rheumatol. 2001;19(1):108.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"38_CR48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"RM Egeler","year":"2007","unstructured":"Egeler RM, Webb D, Winiarski J, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0038-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-013-0038-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0038-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:23:01Z","timestamp":1715584981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-013-0038-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,29]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s40272-013-0038-0","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,29]]}}}